CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE TO COMPLETE YOUR REGISTRATION TO JOIN US IN NEW ORLEANS, LA.

CAN’T MAKE IT TO NEW ORLEANS? CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE AND SELECT THE LIVE STREAMING OPTION TO PARTICIPATE VIRTUALLY.

Friday, October 9, 2026
Registration and Lunch: 11:30 AM – 12:00 PM CT
Symposium: 12:00 PM – 1:00 PM CT
Location: Loews New Orleans
300 Poydras Street, New Orleans, LA 70130
Meeting Room: New Orleans Louisiana Ballroom I/II, 10th Floor
 

Faculty 

Paul S. Bernstein, MD, PhD
Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences
Vice-Chair for Clinical Research
Chief, Retina Division
Moran Eye Center
University of Utah School of Medicine
Salt Lake City, UT

Arshad M. Khanani MD, MA, FASRS
Clinical Professor
University of Nevada, Reno School of Medicine
Managing Partner, Director of Clinical Research, Director of Fellowship
Sierra Eye Associates
Reno, NV

Yasir Sepah, MBBS
Assistant Professor (Research) of Ophthalmology
Member, Maternal & Child Health Research Institute
Member, Wu Tsai Neurosciences Institute 
Stanford University
Stanford, CA
 

Target Audience 

This activity has been designed to meet the educational needs of general ophthalmologists, pediatric ophthalmologists, retina specialists, ophthalmology residents, and retina fellows. It may also benefit optometrists, genetic counselors, low vision specialists, and other healthcare providers who manage patients with inherited retinal diseases.

Not affiliated with the official program of AAO 2026. 
 

Educational Provider

This activity is provided by Paradigm Medical Communications, LLC.  

 

Supporter Acknowledgment 

This activity is supported by an educational grant from Belite Bio.
 

Program Overview

Stargardt disease (STGD1), the most common inherited macular dystrophy, causes progressive central vision loss (often early in life), placing a tremendous long-term burden on patients and their families. No FDA-approved treatment exists today, but that is poised to change. Several investigational therapies, including oral retinoid-cycle modulators and gene-based approaches, are advancing through the pipeline, raising the stakes for early and accurate detection. Join us live at the American Academy of Ophthalmology or via livestream for an update on diagnostics, genetics, and where the treatment landscape is headed, so you are ready to recognize, test, and counsel patients as this field moves forward.
 

Learning Objectives

Upon completion of this activity, participants should be able to:

• Recognize clinical and imaging features of STGD1
• Describe the role of genetic testing in patients with suspected STGD1 
• Discuss mechanisms of action and clinical trial evidence for emerging STGD1 therapies to inform patient counseling

Agenda

11:30 AM – 12:00 PM CT Registration and Complimentary Lunch
12:00 PM – 1:00 PM CT Clinical Program
                

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

PA Continuing Education 

PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 

Nurse Practitioner Continuing Education 

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 

Disclosure of Relevant Financial Relationships 

In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months. Disclosure information about relevant financial relationships with ineligible companies (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity.

CME Inquiries: For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.
 

Fee Information

There is no fee required for participation in this activity.
 

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc).  Please contact Paradigm prior to the event at medicaleducation@paradigmmc.org.


Click the "Register Now" button. Once registered, you will receive an email confirmation with the event details.

© 2026 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.